Jim Cramer Says You Should Buy These 5 Stocks

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 83

Johnson & Johnson (NYSE:JNJ) makes and sells healthcare products. Cramer was bullish on the stock during the Discussed Stock segment of his show on May 2, highlighting that the drop in the share prices of “great American firms” like Johnson & Johnson was an opportunity to buy. He added that once inflation is broken, investors will not have time to buy the shares at such great prices.

On April 20, Credit Suisse analyst Matt Miksic kept an Outperform rating on Johnson & Johnson (NYSE:JNJ) stock and raised the price target to $205 from $200, noting the better-than-expected growth for the firm across key segments in the past few months. 

At the end of the fourth quarter of 2021, 83 hedge funds in the database of Insider Monkey held stakes worth $7.3 billion in Johnson & Johnson (NYSE:JNJ), compared to 88 in the previous quarter worth $6.8 billion.

You can also take a peek at Why These 10 Stocks Are Trending on Monday and 10 ETFs to Buy and Hold for the Next 10 Years.

Follow Insider Monkey on Twitter